SE321676B - - Google Patents

Info

Publication number
SE321676B
SE321676B SE3179/66A SE317966A SE321676B SE 321676 B SE321676 B SE 321676B SE 3179/66 A SE3179/66 A SE 3179/66A SE 317966 A SE317966 A SE 317966A SE 321676 B SE321676 B SE 321676B
Authority
SE
Sweden
Application number
SE3179/66A
Inventor
C Huebner
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of SE321676B publication Critical patent/SE321676B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE3179/66A 1962-06-19 1966-03-10 SE321676B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20343662A 1962-06-19 1962-06-19
US21189462A 1962-07-23 1962-07-23
US267810A US3253037A (en) 1962-06-19 1963-03-25 N-2-alkynyl-amino-benzocylo-alkanes

Publications (1)

Publication Number Publication Date
SE321676B true SE321676B (de) 1970-03-16

Family

ID=27394548

Family Applications (3)

Application Number Title Priority Date Filing Date
SE6752/63A SE317370B (de) 1962-06-19 1963-06-18
SE3179/66A SE321676B (de) 1962-06-19 1966-03-10
SE3178/66A SE321926B (de) 1962-06-19 1966-03-10

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE6752/63A SE317370B (de) 1962-06-19 1963-06-18

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE3178/66A SE321926B (de) 1962-06-19 1966-03-10

Country Status (10)

Country Link
US (1) US3253037A (de)
AT (2) AT244331B (de)
BE (1) BE633762A (de)
BR (1) BR6349933D0 (de)
CH (3) CH462154A (de)
DE (1) DE1443599A1 (de)
ES (1) ES289141A1 (de)
FR (1) FR3290M (de)
GB (1) GB1003686A (de)
SE (3) SE317370B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187017A (en) * 1966-07-16 1970-04-08 Aspro Nicholas Ltd Substituted 1-Amino Indanes and Tetrahydronaphthalens
US3485874A (en) * 1966-05-04 1969-12-23 Chinoin Gyogyszer Es Vegyeszet Ortho and para bromophenyl isopropyl methylamines
US3852339A (en) * 1970-06-15 1974-12-03 Squibb & Sons Inc Aminoalkoxyphenylurea derivatives
FR2319332A1 (fr) * 1975-07-28 1977-02-25 Roussel Uclaf Nouveaux derives de l'aminobenzocycloheptene et leurs sels, procede de preparation et application a titre de medicaments desdits produits
US4320148A (en) * 1980-11-24 1982-03-16 Smithkline Corporation 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
US4542153A (en) * 1981-05-06 1985-09-17 The Ohio State University Research Foundation Methods for changing calcium metabolism within the cells of a mammal
US4393226A (en) * 1981-05-06 1983-07-12 The Ohio State University Research Foundation Compounds and methods for changing calcium metabolism within the cells of a mammal
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
IL109647A (en) * 1989-02-27 1997-04-15 Lilly Co Eli Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetra- hydronaphthalenes and 3-aminochromanes
US5744500A (en) * 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
IL92952A (en) * 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
IL99759A (en) * 1991-10-16 1997-06-10 Teva Pharma Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
EP0738149B1 (de) * 1994-01-10 2006-11-29 Teva Pharmaceutical Industries, Ltd. 1-aminoindanderivate und zusammensetzungen hiervon
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
DE69738275T2 (de) 1996-12-18 2008-08-28 Teva Pharmaceutical Industries Ltd. Aminoindanderivate
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
EP1827409B1 (de) * 2004-11-24 2011-08-24 Teva Pharmaceutical Industries, Ltd. Im mund zerfallende zusammensetzungen von rasagilin
AU2006252540B2 (en) * 2005-06-02 2011-12-01 Jenrin Discovery MAO-B inhibitors useful for treating obesity
JP2009521402A (ja) * 2005-11-17 2009-06-04 テバ ファーマシューティカル インダストリーズ リミティド プロパルギル化アミノインダンの分離のための方法
CN103142570A (zh) * 2005-12-09 2013-06-12 耶路撒冷希伯来大学伊森姆研究发展公司 低剂量Ladostigil 用于神经保护的用途
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
EP2053033A1 (de) 2007-10-26 2009-04-29 Bayer Schering Pharma AG Verbindungen zur Verwendung bei der Abbildung, Diagnose und/oder Behandlung von Erkrankungen des zentralen Nervensystems oder von Tumoren
KR101523195B1 (ko) 2007-12-24 2015-05-27 시플라 리미티드 프로파길화된 아미노인단 유도체의 합성방법
EA201170181A1 (ru) * 2008-07-11 2011-08-30 Синтон Бв Полиморфные формы разагилина гидрохлорида
EP2657221A1 (de) 2008-11-20 2013-10-30 Dr. Reddy's Laboratories Ltd. Herstellung von Rasagilin und Salzen davon
DK2451771T3 (da) * 2009-07-09 2014-09-08 Ratiopharm Gmbh Salte af rasagilin og farmaceutiske fremstillingsmåder heraf
EP2325159A1 (de) 2009-11-24 2011-05-25 LEK Pharmaceuticals d.d. Neuartige Salze von Rasagilin
EP2610239A1 (de) 2012-01-02 2013-07-03 Dr. Reddy's Laboratories Ltd. Herstellung von Rasagilin-Hemitartrat
EP3448519A4 (de) * 2016-04-29 2020-01-22 Board Of Regents, The University Of Texas System Sigma-rezeptor-bindemittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201470A (en) * 1965-08-17 Chsx c cech

Also Published As

Publication number Publication date
GB1003686A (en) 1965-09-08
FR3290M (fr) 1965-05-03
DE1443599A1 (de) 1968-10-24
CH455752A (de) 1968-05-15
BR6349933D0 (pt) 1973-08-28
SE317370B (de) 1969-11-17
AT244331B (de) 1965-12-27
AT244951B (de) 1966-02-10
CH466269A (de) 1968-12-15
US3253037A (en) 1966-05-24
ES289141A1 (es) 1963-11-16
CH462154A (de) 1968-09-15
SE321926B (de) 1970-03-23
BE633762A (fr) 1963-12-18

Similar Documents

Publication Publication Date Title
BE629418A (de)
BE628495A (de)
BE628345A (de)
SE321926B (de)
BE624220A (de)
BE623488A (de)
BE620787A (de)
BE630626A (de)
BE624831A (de)
BE628692A (de)
BE628305A (de)
BE620124A (de)
BE625465A (de)
BE632285A (de)
BE630096A (de)
BE626188A (de)
BE630814A (de)
BE614757A (de)
BE622730A (de)
BE616920A (de)
BE632314A (de)
BE626517A (de)
BE618562A (de)
BE631375A (de)
BE627819A (de)